Related content

Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients

By Benlalam Houssem   Vignard Virginie   Khammari Amir   Bonnin Annabelle   Godet Yann   Pandolfino Marie-Christine   Jotereau Francine   Dreno Brigitte   Labarrière Nathalie  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 4, 2007-04 ,pp. : 515-526

Springer Publishing Company

Access to resources Recommend Favorite

Melan-A specific CD8+ T lymphocytes after hyperthermic isolated limb perfusion: A pilot study in patients with in-transit metastases of malignant melanoma

By Olofsson Roger  

International Journal of Hyperthermia, Vol. 29, Iss. 3, 2013-05 ,pp. : 234-238

Informa Healthcare

Access to resources Recommend Favorite

Detection of circulating tumor lysate–reactive CD4⁺ T cells in melanoma patients

By Ladekarl Morten   Agger Ralf   Fleischer Charlotte   Hokland Marianne   Hulgaard Egil   Kirkin Alexei   Maase Hans   Petersen Mikkel   Rytter Carsten   Zeuthen Jesper   Gundersen Hans  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 6, 2004-06 ,pp. : 560-566

Springer Publishing Company

Access to resources Recommend Favorite

The cytotoxic T cell response to peptide analogs of the HLA-A*0201-restricted MUC1 signal sequence epitope, M1.2

By Mitchell Malcolm   Lund Teri   Sewell Andrew   Marincola Francesco   Paul Elyse   Schroder Kim   Wilson Darcy   Kan-Mitchell June  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 3, 2007-03 ,pp. : 287-301

Springer Publishing Company

Access to resources Recommend Favorite

CD8⁺ T lymphocytes isolated from renal cancer patients recognize tumour cells through an HLA- and TCR/CD3-independent pathway

By Lionello Ilaria   Mangia Patrizia   Gattinoni Luca   Pende Daniela   Cippone Arcadi   Sensi Marialuisa   Rigatti Patrizio   Traversari Catia  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 7, 2007-07 ,pp. : 1065-1076

Springer Publishing Company

Access to resources Recommend Favorite